Form 8-K - Current report:
SEC Accession No. 0001437749-14-020098
Filing Date
2014-11-10
Accepted
2014-11-07 19:43:55
Documents
4
Period of Report
2014-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bota20141107_8k.htm 8-K 20088
2 EXHIBIT 99.1 ex99-1.htm EX-99 153988
3 headerb.jpg GRAPHIC 7598
4 headera.jpg GRAPHIC 9113
  Complete submission text file 0001437749-14-020098.txt   198765
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 141206299
SIC: 2836 Biological Products, (No Diagnostic Substances)